Valeria Cognigni

Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario

Luca Cantini, Giulia Mentrasti, Gian Luigi Russo et al. · ESMO Open · 2022 · 65 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

The Gustave Roussy Immune (GRIm)-Score Variation Is an Early-on-Treatment Biomarker of Outcome in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Pembrolizumab

Edoardo Lenci, Luca Cantini, Federica Pecci et al. · Journal of Clinical Medicine · 2021 · 45 citations · Full text

Medicine, Immunology, Oncology +17

Alarming Drop in Early Stage Colorectal Cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study

Giulia Mentrasti, Luca Cantini, Clizia Zichi et al. · The Oncologist · 2022 · 32 citations · Full text

Medicine, Oncology, Cancer Screening +16

Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study

Federica Pecci, Luca Cantini, Valeria Cognigni et al. · The Oncologist · 2023 · 17 citations · Full text

Medicine, Immunology, Oncology +17

BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma

Albero Murrone, Luca Cantini, Federica Pecci et al. · Journal of Thoracic Disease · 2021 · 12 citations · Full text

Medicine, Oncology, Pathology +17